Bexarotene in Treating Patients With Metastatic Breast Cancer
Status:
Completed
Trial end date:
2003-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Randomized phase II trial to study the effectiveness of bexarotene in treating
patients who have metastatic breast cancer.